Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies

The unprecedented in recent history global COVID-19 pandemic urged the implementation of all existing vaccine platforms to ensure the availability of the vaccines against COVID-19 to every country in the world. Despite the multitude of high-quality papers describing clinical trials of different vacc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kozlovskaya, Liubov I., Piniaeva, Anastasia N., Ignatyev, Georgy M., Gordeychuk, Ilya V., Volok, Viktor P., Rogova, Yulia V., Shishova, Anna A., Kovpak, Anastasia A., Ivin, Yury Yu., Antonova, Liliya P., Mefyod, Kirill M., Prokosheva, Lyubov S., Sibirkina, Anna S., Tarasova, Yuliya Yu., Bayurova, Ekaterina O., Gancharova, Olga S., Illarionova, Victoria V., Glukhov, Grigory S., Sokolova, Olga S., Shaitan, Konstantin V., Moysenovich, Anastasia M., Gulyaev, Stanislav A., Gulyaeva, Tatiana V., Moroz, Andrey V., Gmyl, Larissa V., Ipatova, Elena G., Kirpichnikov, Mikhail P., Egorov, Alexey M., Siniugina, Aleksandra A., Ishmukhametov, Aydar A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439218/
https://www.ncbi.nlm.nih.gov/pubmed/34427172
http://dx.doi.org/10.1080/22221751.2021.1971569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439218/
https://www.ncbi.nlm.nih.gov/pubmed/34427172
http://dx.doi.org/10.1080/22221751.2021.1971569

Ejemplares similares